(Q40521090)

21 September 2017

Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line (English)

1 reference

21 September 2017

Pseudomonas aeruginosa

0 references

author

Henry V. Baker

7

1 reference

21 September 2017

Isabel Virella-Lowell

1

1 reference

21 September 2017

John-David Herlihy

2

1 reference

21 September 2017

Barry Liu

3

1 reference

21 September 2017

Cecilia Lopez

4

1 reference

21 September 2017

Pedro Cruz

5

1 reference

21 September 2017

Chris Muller

6

1 reference

21 September 2017

Terence R Flotte

8

1 reference

21 September 2017

1 September 2004

1 reference

21 September 2017

1 reference

21 September 2017

10

1 reference

21 September 2017

562-573

1 reference

21 September 2017

3

1 reference

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Interleukin-10 and the interleukin-10 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

The use of anti-inflammatory medications in cystic fibrosis: trends and physician attitudes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Corticosteroids and ibuprofen in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Anti-inflammatory therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Effect of high-dose ibuprofen in patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Therapies aimed at airway inflammation in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Anti-inflammatory gene therapy directed at the airway epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Aerosol α1 -antitrypsin treatment for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

A Cystic Fibrosis Bronchial Epithelial Cell Line: Immortalization by Adeno-12-SV40 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Gene expression from adeno-associated virus vectors in airway epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Pseudomonas-epithelial cell interactions dissected with DNA microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.06.215

10.1016/J.YMTHE.2004.06.215

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference